Differences between CD8+ T cells in lupus-prone (NZB × NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influece autoimmunity in the lupus model

European Journal of Immunology

Volumn 34, Issue 9, 2004, Pages 2489-2499

  Karpouzas, George A ^a   La Cava, Antonio ^b   Ebling, Fanny M ^b   Singh, Ram Raj ^c   Hahn, Bevra H ^b,d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Inhibitory CD8+ T cells; Lupus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA; AUTOANTIBODY; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CELL SECRETION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; GENE TARGETING; HELPER CELL; IMMUNIZATION; MEMORY CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; ANIMAL; APOPTOSIS; BIOSYNTHESIS; C57BL MOUSE; CD8+ T LYMPHOCYTE; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NEW ZEALAND BLACK MOUSE;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED NZB; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4644236340     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200424978     Document Type: Article

References (31)

1. Hahn, B. H., Antibodies to DNA. N. Engl. J. Med. 1998. 338: 1359-1368.
2. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 1989. 143: 103-112.
3. Singh, R. R., Hahn, B. H., Tsao, B. P. and Ebling, F. M., Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus. J. Clin. Invest. 1998. 102: 1841-1849.
4. H-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J. Exp. Med. 2002. 196: 731-741.
5. + T suppressor cell function in patients with active systemic lupus erythematosus. J. Immunol. 2001. 166: 6452-6457.
6. Singh, R. R., Ebling, F. M., Albuquerque, D. A., Saxena, V., Kumar, V., Giannini, E. H., Marion, T. N., Finkelman, F. D. and Hahn, B. H., Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol. 2002. 169: 587-594.
7. Singh, R. R., Kumar, V., Ebling, F. M., Southwood, S., Sette, A., Sercarz, E. E. and Hahn, B. H., T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 1995. 181: 2017-2027.
8. Jouanne, C., Avrameas, S. and Payelle-Brogard, B., A peptide derived from a polyreactive monoclonal anti-DNA natural antibody can modulate lupus development in (NZB × NZW) F1 mice. Immunology 1999. 96: 333-339.
9. Zhang, X., Smith, D. S., Guth, A. and Wysocki, L. J., A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J. Immunol. 2001. 166: 1562-1571.
10. Williams, W. W., Staines, N. A., Muller, S. and Isenberg, D. A., Human T cell responses to autoantibody variable region peptides. Lupus 1995. 4: 464-471.
11. Dayan, M., Segal, R., Sthoeger, Z., Waisman, A., Brosh, N., Elkayam, O. et al., Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. J. Clin. Immunol. 2000. 20: 187-194.
12. Singh, R.R., Potential use of peptides and vaccination to treat systemic lupus erythematosus. Curr. Opin. Rheumatol. 2000. 12: 399-406.
13. + regulatory T cell subsets. J. Leukoc. Biol. 2003. 74: 471-478.
14. Shedlock, D. J. and Shen, H., Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003. 300: 337-340.
15. Cerwenka, A., Carter, L. L., Reome, J. B., Swain, S. L. and Dutton, R. W., In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol. 1998. 161: 97-105.
16. Rozzo, S. J., Drake, C. G., Chiang, B. L., Gershwin, M. E. and Kotzin, B. L., Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. J. Immunol. 1994. 153: 1340-1351.
17. + cells. Clin. Exp. Immunol. 1992. 90: 260-265.
18. Ohtsuka, K., Gray, J. D., Quismorio, F. P. Jr., Lee, W. and Horwitz, D. A., Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-β. Lupus 1999. 8: 95-102.
19. + Tand NK cells. J. Exp. Med. 1994. 180: 1937-1942.
20. Ohtsuka, K., Gray, J. D., Stimmler, M. M., Toro, B. and Horwitz, D. A., Decreased production of TGFβ by lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 1998. 160: 2539-2545.
21. + cells to support autoantibody synthesis. Arthritis Rheum. 1990. 33: 1216-1225.
22. Krakauer, R. S., Waldmann, T. A. and Strober, W., Loss of suppressor T cells in adult NZB/NZW mice. J. Exp. Med. 1976. 144:663-673.
23. Morimoto, C., Reinherz, E. L., Schlossman, S. F., Schur, P. H., Mills, J. A. and Steinberg, A. D., Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J. Clin. Invest. 1980. 66: 1171-1174.
24. Pachner, A. R. and Kantor, F. S., In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis. Clin. Exp. Immunol. 1984. 56: 659-668.
25. Ellerman, K. E., Powers, J. M. and Brostoff, S. W., A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis. Nature 1988. 331: 265-267.
26. + suppressive regulatory T lymphocytes which down-regulates experimental autoimmune orchitis (EAO) in mice. Clin. Exp. Immunol. 1994. 96: 138-145.
27. Sun, D., Whitaker, J. N. and Wilson, D. B., Regulatory T cells in experimental allergic encephalomyelitis. III. Comparison of disease resistance in Lewis and Fischer 344 rats. Eur. J. Immunol. 1999. 29: 1101-1106.
28. - T cells in an autoimmune disease model. J. Clin. Invest. 2003. 112: 1037-1048.
29. Adachi, Y., Inaba, M., Sugihara, A., Koshiji, M., Sugiura, K., Amoh, Y., Mori, S., Kamiya, T., Genba, H. and Ikehara, S., Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW × BXSB) F1 mice. Immunobiology 1998. 198: 451-464.
30. Ruiz, P. J., Zinger, H. and Mozes, E., Effect of injection of anti-CD4 and anti-CD8 monoclonal antibodies on the development of experimental systemic lupus erythematosus in mice. Cell. Immunol. 1996. 167: 30-37.
31. Blank, M., Ben-Bassat, M. and Shoenfeld, Y., Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA idiotype. Cell. Immunol. 1991. 137: 474-486.